Latest filing published 16 Aug 2021 for Arix Bioscience plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Lyne: trading record in brief
Robert Lyne is a declared insider of Arix Bioscience plc, with filings sourced from RNS (LSE). We count 4 filings; the first trade dates from 7 June 2018 and the latest from 13 August 2021.
No open-market sale appears; the market trades are 1 purchase worth €23k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 option exercises.
The record was last updated on 16 August 2021 with an option exercise in Arix Bioscience plc. The last insider purchase was made public on 17 April 2020, 2,396 days ago. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Robert Lyne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 352,335 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:SBLFIPQBSFCSJQQDTTKLQXBG
- 471,676 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:202007010200PR_NEWS_UKDISCLO_0030-1
- 23,255 shares@ £0.86London Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:202004170959PR_NEWS_UKDISCLO_0079-0Canonical exit: 15 Jul 2020 (T+90)
- 111,940 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-3
4 of 4 declarations